Nipro Medical Corporation has received 510(K) clearance from the U.S. Food and Drug Administration for its Elisio Polynephron single use, high-flux, hollow-fiber dialyzer. The Elisio features a Polynephron membrane similar in function to that of a human kidney, and delivers excellent biocompatibility, hemocompatibility, and solute-removal performance, resulting in superior clearances for better patient outcomes, according to a news release from Nipro.

“Elisio is designed to deliver an elevated benefits platform to the market, especially in clearance performance of small to middle molecules, and it delivers on these objectives,” said Joe Dawson, Senior Vice President of Nipro North America.